| Original language | English (US) |
|---|---|
| Pages (from-to) | 220-222 |
| Number of pages | 3 |
| Journal | Leukemia and Lymphoma |
| Volume | 55 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2014 |
| Externally published | Yes |
Fingerprint
All Science Journal Classification (ASJC) codes
- Hematology
- Oncology
- Cancer Research
Cite this
Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency. / Stessman, Holly; Mansoor, Aatif; Linden, Michael A.; Van Ness, Brian; Baughn, Linda B.
In: Leukemia and Lymphoma, Vol. 55, No. 1, 01.01.2014, p. 220-222.Research output: Contribution to journal › Letter
}
TY - JOUR
T1 - Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency
AU - Stessman, Holly
AU - Mansoor, Aatif
AU - Linden, Michael A.
AU - Van Ness, Brian
AU - Baughn, Linda B.
PY - 2014/1/1
Y1 - 2014/1/1
UR - http://www.scopus.com/inward/record.url?scp=84891367302&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84891367302&partnerID=8YFLogxK
U2 - 10.3109/10428194.2013.797575
DO - 10.3109/10428194.2013.797575
M3 - Letter
VL - 55
SP - 220
EP - 222
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
SN - 1042-8194
IS - 1
ER -